BioSpace News Archive

Feb. 6, 2020 14:00 UTC VIENNA, Va.--( BUSINESS WIRE )-- CEL-SCI Corporation (NYSE American: CVM) , a Phase 3 cancer immunotherapy company, announced today that Geert Kersten, Chief Executive Officer, will be presenting at the 2020 BIO CEO & Investor Conference in New York, NY on Monday, February 10, 2019 at 3:45 p.m.

With global health concerns regarding the 2019 Novel Coronavirus (2019-nCoV) continuing to rise, hospital administrators and healthcare professionals are evaluating their options for providing patients with blood products that have an added level of safety.

HASBROUCK HEIGHTS, N.J., Feb. 06, 2020 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to announce the new appointment of Russell I. Thomson PhD, FRSC to the position of Nymox Vice President of Quality and Regulatory Affairs.

A well-known market intelligence company, Infiniti Research, has announced the completion of its latest article on identifying key regenerative medicine manufacturing challenges.

Juvare, the leader in critical incident preparedness and response technology, announced today that the company is working closely with public health departments and health systems across the country, in conjunction with the Department of Health and Human Services and the Centers for Disease Control and Prevention, to prepare the U.S. for potential coronavirus outbreaks.

The HydraFacial Company announced today the release of their new HydraFacial ReGen GF growth factor booster featuring patented M-007 delivery technology.

The Akesis Galaxy® RTx, an advanced gamma stereotactic radiosurgery system with continuous 360º rotational technology, has received 510 clearance from the U.S. Food and Drug Administration.

The American College of Prosthodontists invite dental professionals to Chicago, Feb. 18-19 [06-February-2020] CHICAGO , Feb. 6, 2020 /PRNewswire/ -- The American College of Prosthodontists (ACP) is pleased to announce the 2020 Digital Dentistry Symposium is returning to Chicago , Feb 18-19 . This year will provide attendees ‘Solutions & Strategies for Success’

Combination gene therapy developed at Wyss Institute and Harvard Medical School treats four age-related conditions

macro-eyes will bring AI to where it will do the greatest good